Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
31.99
+0.03 (0.09%)
Oct 19, 2026, 12:22 PM EDT - Market open
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $977.28 million as of October 19, 2026. It is the 10,244th most valuable company in the world and the 2,246th biggest in the United States. Its market cap has increased by 52.17% in one year.
Market Cap
977.28M
Enterprise Value
747.12M
1-Year Change
52.17%
Global Rank
Country Rank
#2,246 United States
Category
ChartMarket Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $977.28M, an increase of 694.21%. That is a compound annual growth rate of 33.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 977.28M | -13.93% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 3.83B |
| Veracyte | 3.47B |
| CareDx | 3.31B |
| NeoGenomics | 2.14B |
| GeneDx Holdings | 1.90B |
| Personalis | 1.67B |
| Freenome | 1.26B |
| OPKO Health | 1.14B |